{
    "nct_id": "NCT04948619",
    "official_title": "Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer",
    "inclusion_criteria": "1. Written informed consent, HIPAA authorization for release of personal health information, and assent, when applicable from the subject, parent, or legal guardian.\n2. Age greater than or equal to 2 years and less than 22 years at the time of consent\n3. Lansky/Karnofsky Performance Status of greater than 50 (ECOG less than 2) within 30 days prior to date of enrollment\n4. Histological or cytological confirmation of any malignancy treated by the Pediatric Oncology team of Levine Children's Hospital\n5. History of any malignant diagnosis treated with at least one cycle of cancer directed systemic therapy\n6. Must be no more than 60 days from last dose of cancer directed systemic therapy at time of enrollment\n7. As determined by the enrolling physician, ability of the subject and parent/caregiver to understand and comply with study procedures for the entire length of the study\nHealthy volunteers allowed\nMust have minimum age of 2 Years\nMust have maximum age of 21 Years",
    "exclusion_criteria": "1. Malignant disease treated with observation, surgery, or radiotherapy alone\n2. Known coexisting immunodeficiency\n3. Subjects with normal baseline titers for all investigated vaccines\n4. Known pregnancy\n5. Documented previous severe allergic reaction to any vaccine or component of a vaccine\n6. Documented current/active, severe infection, as determined by the investigator",
    "miscellaneous_criteria": ""
}